Skip to main content
. 2019 Nov 19;9:17081. doi: 10.1038/s41598-019-53051-2

Figure 2.

Figure 2

(A) Survival rate for all hepatocellular carcinoma (HCC) patients within cohort (n = 969) in months since HCC diagnosis. (B) OS for HCC patients by main HCC treatment method. Patients receiving liver transplantation (n = 125). Patients undergoing tumor resection (n = 112), interventional oncology (IO) (n = 478), systemic therapy (n = 94) and supportive management (n = 141) (overall p < 0.0001).